Effects of SIMEOX on Flow and Volume in Healthy Subjects and Patients With COPD

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

November 16, 2021

Study Completion Date

November 16, 2021

Conditions
HealthyPulmonary Disease, Chronic Obstructive
Interventions
DEVICE

SIMEOX

SIMEOX is a device generating a succession of gentle depression at the mouth.

DEVICE

PEP

A PEP device (Pari-PEP) will be used to provoke a positive expiratory pressure while exhaling, thereby stabilizing the airways during expiration.

OTHER

Spontaneous Exhalation

A slow vital capacity maneuver will be performed according to the guidelines, from total lung capacity to residual volume

Trial Locations (1)

1200

Cliniques universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT04150601 - Effects of SIMEOX on Flow and Volume in Healthy Subjects and Patients With COPD | Biotech Hunter | Biotech Hunter